Skip to main content
Signal8

Soleus Capital Management, L.P.

Soleus Capital Management, L.P. is an Investment Adviser institutional filer with the SEC under CIK 1802630, reporting 97 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-11

Top 10 portfolio positions

The largest reported holdings in Soleus Capital Management, L.P.'s most recent 13F filing, ranked by reported market value.

  1. KRYSTAL BIOTECH INC (KRYS)
  2. CELCUITY INC (CELC)
  3. TG THERAPEUTICS INC (TGTX)
  4. INSULET CORP (PODD)
  5. NOVOCURE LTD (NVCR)
  6. UNITED THERAPEUTICS CORP DEL (UTHR)
  7. INSPIRE MED SYS INC (INSP)
  8. RIGEL PHARMACEUTICALS INC (RIGL)
  9. ANI PHARMACEUTICALS INC (ANIP)
  10. BETA BIONICS INC (BBNX)
/